The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ACRIN 6691 monitoring and predicting breast cancer neoadjuvant chemotherapy response using diffuse optical spectroscopic imaging (DOSI).
B. J. Tromberg
No relevant relationships to disclose
J. A. Butler
No relevant relationships to disclose
D. A. Mankoff
No relevant relationships to disclose
S. J. Isakoff
No relevant relationships to disclose
N. M. Hylton
No relevant relationships to disclose
A. G. Yodh
No relevant relationships to disclose
D. Boas
No relevant relationships to disclose
K. Paulsen
No relevant relationships to disclose
B. W. Pogue
No relevant relationships to disclose
P. A. Kaufman
No relevant relationships to disclose
R. S. Mehta
No relevant relationships to disclose
P. M. Carpenter
No relevant relationships to disclose
A. Cerussi
No relevant relationships to disclose
Z. Zhang
No relevant relationships to disclose
D. M. Hartfeil
No relevant relationships to disclose
D. L'Heureux
No relevant relationships to disclose